CVS Health: EPS down 44% in Q4

(CercleFinance.com) - CVS Health reports adjusted EPS for the final quarter of 2024 down 44% to $1.
19 and adjusted operating profit down more than 35% to $2.73 billion, despite revenue growth of 4.2% to $97.7 billion.

The group explains that its drop in profits was mainly due to declining operating results in the healthcare benefits segment, reflecting continued utilization pressure and an unfavorable impact related to Medicare Advantage star ratings.

Posting full-year 2024 adjusted EPS of $5.42 and cash flow from operations of $9.1 billion, CVS Health expects a target range of $5.75 to $6 respectively, and a target of around $6.5 billion for 2025.

Copyright (c) 2025 CercleFinance.com. All rights reserved.